查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609542

骨關節炎治療市場規模、佔有率、趨勢分析報告：按藥物類型、解剖結構、給藥途徑、銷售銷售管道、最終用途、地區和細分市場預測，2025-2030

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Anatomy, By Route Of Administration, By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

骨關節炎治療市場的成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球骨關節炎（OA）治療市場規模將達到135.7億美元，2025年至2030年複合年成長率為6.89%。

骨關節炎治療市場正在不斷成長，特別是由於老年社會中骨關節炎病例的增加。光在美國就有超過 3,250 萬人患有 OA，對有效治療的需求不斷成長。持續的研究和開發重點是創造新的治療方法，特別是了解 OA 疾病並開發解決方案來應對其挑戰。

由於其緻密的組織結構，治療骨關節炎很困難，但隨著關節內給藥等新型藥物的採用，標靶藥物傳遞的發展正在加速。研發部門正在積極探索緩解疾病藥物和生物適應性載體，以促進骨關節炎創新治療方法的開發。 OrthoTrophix, Inc. 在 BIO2022 上公佈了 TPX-100 治療膝骨關節炎的臨床資料和註冊計劃，市場相關人員正在採取舉措為市場擴張做出貢獻。

此外，主要製藥公司和研究機構正在做出重大努力，特別是在緩解疾病治療方法的研究和開發領域。例如，Bioscenic 在 2024 年 OARSI 世界大會上公佈的 3 期資料證明了 JTA-004 在治療嚴重發炎性膝骨關節炎方面的功效。事後分析得出結論，JTA-004 安全有效，並為這種特定的病理亞型提供有針對性的疼痛管理。藥物輸送和緩解疾病藥物方面的這些進展已通過學術會議演講和有利的測試結果得到證明，並有助於擴大骨關節炎新療法的市場。

此外，由於雙磷酸鹽和 Synvisc-ONE 注射劑等個人化治療的採用，OA 市場正在經歷顯著成長。此外，製藥公司和研究機構正在積極致力於開發針對 OA 的個人化和基於細胞的治療方法。 2023 年 12 月，哥倫比亞大學的研究人員在成年小鼠幹細胞中取得了突破性發現，可以維持關節軟骨健康。幹細胞的喪失會導致老齡化和損傷而導致骨關節炎的發生。

透過投資這一領域，公司可以滿足不斷變化的需求並獲得競爭優勢。透過主導創新藥物開發，公司確立了自己的領跑者地位並鞏固了其市場地位。個人化骨關節炎治療的出現和細胞治療方法的進步是市場擴張的關鍵因素，使公司成為該領域的領導者。

骨關節炎治療市場報告亮點

  • 按藥物類型分類，關節內粘稠補充療法藥物在2024 年佔據最大佔有率，為37.06%，並且由於其在治療OA 症狀方面的採用和有效性，預計在預測期內將以最快的複合年成長率成長。
  • 從解剖結構來看，膝骨關節炎（KOA）細分市場在2024年將佔據壓倒性的佔有率，達到42.07%。膝骨關節炎（KOA）是全球最常見的慢性關節疾病，其特徵是高致殘率和發病率。
  • 從給藥途徑來看，腸胃外給藥將在 2024 年佔據主要佔有率，因為它具有特定治療的功效、更好的藥物動力學和動態、易於給藥以及在預測期內更高的預期成長率，預計將以複合年成長率成長。
  • 2024年按銷售管道分類的骨關節炎治療細分市場中，組合藥物預計將保持主導地位。
  • 依最終用途分類，2024年醫院藥局領域將佔據壓倒性佔有率，達47.50%。
  • 北美骨關節炎治療市場主導全球產業，2024年佔37.31%。由於多種因素，包括肥胖率高和政府的支持措施，北美市場仍然佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章骨關節炎治療市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 骨關節炎治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章骨關節炎治療市場：藥物類型、估計和趨勢分析

  • 細分儀表板
  • 按藥物類型分類的全球骨關節炎治療市場前景
  • 2018-2030年全球骨關節炎治療市場規模及趨勢分析（依藥物類型）
  • 關節內粘稠補充療法劑
  • 非類固醇消炎劑
    • 止痛藥
    • 皮質類固醇
    • 其他

第5章骨關節炎治療市場：解剖結構、估計與趨勢分析

  • 細分儀表板
  • 全球骨關節炎治療市場波動分析
  • 2018-2030年全球骨關節炎治療市場規模及趨勢分析、解剖結構
  • 膝骨關節炎
  • 髖骨關節炎
  • 手骨關節炎
  • 其他

第6章骨關節炎治療市場：給藥途徑、估計與趨勢分析

  • 細分儀表板
  • 全球骨關節炎治療市場波動分析
  • 2018-2030 年全球骨關節炎治療市場規模與趨勢分析（依給藥途徑）
  • 腸外給藥
  • 局部的
  • 口服給藥

第7章骨關節炎治療市場：按銷售管道估計和趨勢分析

  • 細分儀表板
  • 全球骨關節炎治療市場波動分析
  • 2018-2030年全球骨關節炎治療市場規模及趨勢分析（依銷售管道）
  • 聯合用藥
  • 非處方藥

第8章骨關節炎治療市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球骨關節炎治療市場波動分析
  • 2018-2030 年全球骨關節炎治療市場規模與趨勢分析（依最終用途）
  • 醫院藥房
  • 零售藥房
  • 其他

第9章骨關節炎治療市場：按地區估計和趨勢分析

  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2024年主要企業市場佔有率分析
    • Sanofi SA
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Bayer AG
    • Zimmer Biomet
    • Novartis AG
    • Anika Therapeutics
    • Assertio Therapeutics, Inc.
    • Bioventus
    • Ferring Pharmaceuticals Inc.
Product Code: GVR-4-68040-221-7

Osteoarthritis Therapeutics Market Growth & Trends:

The global osteoarthritis therapeutics market size is expected to reach USD 13.57 billion by 2030, registering a CAGR of 6.89% from 2025 to 2030, according to a new report by Grand View Research, Inc. The osteoarthritis therapeutics market is on the rise, driven by an increase in OA cases, especially among the aging population. In the U.S. alone, there are over 32.5 million OA patients, highlighting the demand for effective treatments. Ongoing research and development efforts are focused on creating new therapies, with a particular emphasis on understanding the disease and developing solutions to address its challenges.

Managing OA proves difficult owing to its dense tissue structure, but the introduction of novel drugs such as intra-articular drug administration has accelerated the development of targeted drug delivery. Researchers are actively exploring disease-modifying drugs and bioadaptive carriers to enhance the development of innovative osteoarthritis treatments. Market players are taking initiatives to contribute to market expansion, as seen with OrthoTrophix, Inc. presenting clinical data and a registration plan for TPX-100 for knee osteoarthritis at BIO 2022.

In addition, significant efforts are being made by key pharmaceutical companies and research institutes in realm of research and development, especially for disease-modifying osteoarthritis drugs. For instance, BioSenic's Phase 3 data presentation at the 2024 OARSI World Congress showcased the efficacy of JTA-004 in treating severe inflammatory knee osteoarthritis. The post hoc analysis concluded that JTA-004 is both safe and effective, offering targeted pain management for this specific subtype of condition. These advancements in targeted drug delivery and disease-modifying drugs, as demonstrated by presentations and positive trial results, are contributing to the expansion of the market for novel osteoarthritis treatments.

Moreover, the market for OA is experiencing significant growth owing to the introduction of personalized medications such as Bisphosphonates (anti-resorptive drugs) and Synvisc-ONE injection. In addition, pharmaceutical companies and research institutions are actively engaged in developing personalized treatments and cell-based therapies for OA. In December 2023, researchers at Columbia University made a breakthrough discovery of stem cells in adult mice capable of maintaining healthy cartilage in joints, with their decline contributing to OA development due to aging and injury.

Investing in this sector offers companies the opportunity to capitalize on evolving demands, thus gaining a competitive advantage. By leading innovative medication development, companies establish themselves as frontrunners, solidifying their position in the market. The advent of personalized OA medications and advancements in cell-based therapies are key drivers of market expansion, empowering companies to emerge as leaders in the field.

Osteoarthritis Therapeutics Market Report Highlights:

  • Based on drug type, the viscosupplementation agents segment accounted for the largest share of 37.06% in 2024 and is expected to grow at the fastest CAGR over the forecast period due to their adoption and efficacy in managing OA symptoms.
  • Based on anatomy, the knee osteoarthritis (KOA) segment held a dominant share of 42.07% in 2024. KOA is one of the most common forms of chronic articular disease and OA worldwide and is characterized by high disability & morbidity rates.
  • Based on route of administration, the parenteral route segment held a dominant share in 2024 and is expected to grow at a CAGR of 7.57% over the forecast period due to its efficacy for certain therapies, better pharmacokinetics and pharmacodynamics, ease of administration, and higher projected growth rate.
  • Prescription drugs are poised to maintain dominance in the osteoarthritis therapeutics market' sales Channel segment in 2024.
  • Based on end-use, the hospital pharmacies segment held a dominant share in 2024, accounting for 47.50%.
  • North America osteoarthritis therapeutics market dominated the global industry and accounted for a 37.31% share in 2024. The North American market maintains its dominance due to several factors, including a high prevalence of obesity and supportive government policies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Anatomy
    • 1.2.3. Route of Administration
    • 1.2.4. Sales Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug type outlook
    • 2.2.2. Anatomy outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Sales channel outlook
    • 2.2.5. End use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High Prevalence of Osteoarthritis
      • 3.2.1.2. Growing Aging Population
      • 3.2.1.3. Technological Advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Side Effects and Adverse Reactions
      • 3.2.2.2. High cost of osteoarthritis therapeutics drugs
  • 3.3. Osteoarthritis Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Osteoarthritis Therapeutics Market: Drug Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Osteoarthritis Therapeutics Market by Drug Type Outlook
  • 4.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 4.4. Viscosupplementation Agents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Nonsteroidal Anti-inflammatory Drugs
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.1. Naproxen
        • 4.5.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.2. Aspirin
        • 4.5.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.3. Diclofenac
        • 4.5.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.4. Ibuprofen
        • 4.5.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.5. Celecoxib
        • 4.5.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.6. Meloxicam
        • 4.5.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.7. Piroxicam
        • 4.5.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.8. Ketoprofen
        • 4.5.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.9. Other NSAIDs
        • 4.5.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Analgesics
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.5.2.1.1. Duloxetine
          • 4.5.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.5.2.1.2. Acetaminophen
          • 4.5.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Corticosteroids
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Osteoarthritis Therapeutics Market: Anatomy Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 5.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Anatomy, 2018 to 2030 (USD Million)
  • 5.4. Knee Osteoarthritis
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Hip Osteoarthritis
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Hand Osteoarthritis
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Osteoarthritis Therapeutics Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 6.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Parenteral Route
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.1. Hyaluronic Acid Injections
        • 6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.2. Corticosteroid Injections
        • 6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.3. Platelet-rich Plasma (PRP) Injections
        • 6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.4. Placental Tissue Matrix (PTM) Injections
        • 6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.5. Acetylsalicylic Acid (ASA) Injections
        • 6.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.6. Others
        • 6.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Topical Route
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Oral Route
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Osteoarthritis Therapeutics Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 7.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 7.4. Prescription Drugs
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Over-the-Counter Drugs
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Osteoarthritis Therapeutics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 8.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
  • 8.4. Hospital Pharmacies
    • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Retail Pharmacies
    • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis by

  • 9.1. Regional Market Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2024
    • 10.3.4. Sanofi SA
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. GlaxoSmithKline plc
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Pfizer Inc.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Bayer AG
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Zimmer Biomet
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Novartis AG
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Anika Therapeutics
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Assertio Therapeutics, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Bioventus
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Ferring Pharmaceuticals Inc.
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 5 North America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 6 North America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 North America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 11 U.S. Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 16 Canada Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 18 Canada Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 22 Europe Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 24 Europe Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 27 Germany Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Germany Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 29 Germany Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 31 UK Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 32 UK Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 UK Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 France Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 36 France Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 37 France Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 France Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 39 France Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Italy Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 41 Italy Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 42 Italy Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 43 Italy Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 44 Italy Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Spain Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 47 Spain Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Spain Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 49 Sapin Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 52 Denmark Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 54 Denmark Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Sweden Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 57 Sweden Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 Sweden Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 59 Sweden Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Norway Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 61 Norway Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 62 Norway Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Norway Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 64 Norway Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 73 Japan Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 75 Japan Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 China Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 77 China Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 78 China Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 China Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 80 China Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 India Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 82 India Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 83 India Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 India Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 85 India Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Australia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 87 Australia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 88 Australia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 89 Australia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 90 Australia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 South Korea Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 92 South Korea Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 93 South Korea Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 South Korea Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 95 South Korea Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Thailand Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 97 Thailand Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 98 Thailand Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Thailand Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 100 Thailand Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 Latin America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 102 Latin America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 103 Latin America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 104 Latin America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 105 Latin America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 106 Latin America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Brazil Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 108 Brazil Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 109 Brazil Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 110 Brazil Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 111 Brazil Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Mexico Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 113 Mexico Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 114 Mexico Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 115 Mexico Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 116 Mexico Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117 Argentina Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 118 Argentina Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 119 Argentina Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Argentina Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 121 Argentina Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 122 MEA Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 123 MEA Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 124 MEA Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 125 MEA Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 126 MEA Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 127 MEA Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 South Africa Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 129 South Africa Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 130 South Africa Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 131 South Africa Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 132 South Africa Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 138 UAE Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 139 UAE Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 140 UAE Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 141 UAE Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 142 UAE Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Osteoarthritis Therapeutics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Osteoarthritis Therapeutics Market snapshot (2024)
  • Fig. 9 Osteoarthritis Therapeutics Market: Segment snapshot (2024)
  • Fig. 10 Competitive Insights (2024)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Osteoarthritis Therapeutics Market driver impact
  • Fig. 15 Osteoarthritis Therapeutics Market restraint impact
  • Fig. 16 Clinical chemistry industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2024
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by drug type
  • Fig. 24 Drug type market share analysis, 2024 & 2030
  • Fig. 25 Segment dashboard
  • Fig. 26 Global Osteoarthritis Therapeutics Market, by drug type, 2018 - 2030 (USD Million)
  • Fig. 27 Viscosupplementation Agents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Nonsteroidal Anti-inflammatory Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Naproxen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Aspirin market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Diclofenac market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Ibuprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Celecoxib market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 34 Meloxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 35 Piroxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 36 Ketoprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 37 Other NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Analgesics market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Duloxetine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 Acetaminophen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Corticosteroids market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 42 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 43 Definition and scope, by Anatomy
  • Fig. 44 Anatomy market share analysis, 2024 & 2030
  • Fig. 45 Segment dashboard
  • Fig. 46 Global Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Fig. 47 Knee Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Hip Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Hand Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 50 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 51 Definition and scope, by Route of Administration
  • Fig. 52 Anatomy market share analysis, 2024 & 2030
  • Fig. 53 Segment dashboard
  • Fig. 54 Global Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 55 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 Hyaluronic acid injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Corticosteroid Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Platelet-rich Plasma (PRP) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 Placental Tissue Matrix (PTM) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 60 Acetylsalicylic Acid (ASA) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Topical Route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Definition and scope, by Sales Channel
  • Fig. 65 Sales Channel market share analysis, 2024 & 2030
  • Fig. 66 Segment dashboard
  • Fig. 67 Global Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Fig. 68 Prescription Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 Over-the-Counter drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Definition and scope, by End Use
  • Fig. 71 End Use market share analysis, 2024 & 2030
  • Fig. 72 Segment dashboard
  • Fig. 73 Global Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Fig. 74 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 78 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 83 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 84 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 85 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 86 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 87 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 88 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 89 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 90 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 91 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 92 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 93 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 94 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 95 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 96 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 97 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 98 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 99 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 100 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 101 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 102 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 103 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 104 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)